338 related articles for article (PubMed ID: 22306319)
1. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.
Gray PC; Vale W
FEBS Lett; 2012 Jul; 586(14):1836-45. PubMed ID: 22306319
[TBL] [Abstract][Full Text] [Related]
2. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic.
Aykul S; Parenti A; Chu KY; Reske J; Floer M; Ralston A; Martinez-Hackert E
J Biol Chem; 2017 Mar; 292(10):4138-4151. PubMed ID: 28126904
[TBL] [Abstract][Full Text] [Related]
4. The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition.
Klauzinska M; Castro NP; Rangel MC; Spike BT; Gray PC; Bertolette D; Cuttitta F; Salomon D
Semin Cancer Biol; 2014 Dec; 29():51-8. PubMed ID: 25153355
[TBL] [Abstract][Full Text] [Related]
5. Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling.
Gray PC; Shani G; Aung K; Kelber J; Vale W
Mol Cell Biol; 2006 Dec; 26(24):9268-78. PubMed ID: 17030617
[TBL] [Abstract][Full Text] [Related]
6. Cripto stabilizes GRP78 on the cell membrane.
Kouznetsova VL; Hu H; Teigen K; Zanetti M; Tsigelny IF
Protein Sci; 2018 Mar; 27(3):653-661. PubMed ID: 29226519
[TBL] [Abstract][Full Text] [Related]
7. An evolving web of signaling networks regulated by Cripto-1.
Nagaoka T; Karasawa H; Castro NP; Rangel MC; Salomon DS; Bianco C
Growth Factors; 2012 Feb; 30(1):13-21. PubMed ID: 22149969
[TBL] [Abstract][Full Text] [Related]
8. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.
Shani G; Fischer WH; Justice NJ; Kelber JA; Vale W; Gray PC
Mol Cell Biol; 2008 Jan; 28(2):666-77. PubMed ID: 17991893
[TBL] [Abstract][Full Text] [Related]
9. CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo.
Spike BT; Kelber JA; Booker E; Kalathur M; Rodewald R; Lipianskaya J; La J; He M; Wright T; Klemke R; Wahl GM; Gray PC
Stem Cell Reports; 2014 Apr; 2(4):427-39. PubMed ID: 24749068
[TBL] [Abstract][Full Text] [Related]
10. Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.
Kim S; Yoon YM; Han YS; Lee JH; Hur J; Lee SH
Cell Prolif; 2018 Oct; 51(5):e12463. PubMed ID: 29722092
[TBL] [Abstract][Full Text] [Related]
11. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells.
Parisi S; D'Andrea D; Lago CT; Adamson ED; Persico MG; Minchiotti G
J Cell Biol; 2003 Oct; 163(2):303-14. PubMed ID: 14581455
[TBL] [Abstract][Full Text] [Related]
12. Cripto favors chondrocyte hypertrophy via TGF-β SMAD1/5 signaling during development of osteoarthritis.
Garcia de Vinuesa A; Sanchez-Duffhues G; Blaney-Davidson E; van Caam A; Lodder K; Ramos Y; Kloppenburg M; Meulenbelt I; van der Kraan P; Goumans MJ; Ten Dijke P
J Pathol; 2021 Nov; 255(3):330-342. PubMed ID: 34357595
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cells are regulated by Cripto, as an intermediary of HIF-1α in the hypoxic bone marrow niche.
Miharada K; Karlsson G; Rehn M; Rörby E; Siva K; Cammenga J; Karlsson S
Ann N Y Acad Sci; 2012 Aug; 1266():55-62. PubMed ID: 22901256
[TBL] [Abstract][Full Text] [Related]
14. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer.
Zoni E; Chen L; Karkampouna S; Granchi Z; Verhoef EI; La Manna F; Kelber J; Pelger RCM; Henry MD; Snaar-Jagalska E; van Leenders GJLH; Beimers L; Kloen P; Gray PC; van der Pluijm G; Kruithof-de Julio M
Oncogene; 2017 Aug; 36(33):4739-4749. PubMed ID: 28394345
[TBL] [Abstract][Full Text] [Related]
15. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
[TBL] [Abstract][Full Text] [Related]
16. Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development.
Andersson O; Bertolino P; Ibáñez CF
Dev Biol; 2007 Nov; 311(2):500-11. PubMed ID: 17936261
[TBL] [Abstract][Full Text] [Related]
17. A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles.
Rodrigues Sousa E; Zoni E; Karkampouna S; La Manna F; Gray PC; De Menna M; Kruithof-de Julio M
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517087
[TBL] [Abstract][Full Text] [Related]
18. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal.
Kelber JA; Shani G; Booker EC; Vale WW; Gray PC
J Biol Chem; 2008 Feb; 283(8):4490-500. PubMed ID: 18089557
[TBL] [Abstract][Full Text] [Related]
19. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.
Yan YT; Liu JJ; Luo Y; E C; Haltiwanger RS; Abate-Shen C; Shen MM
Mol Cell Biol; 2002 Jul; 22(13):4439-49. PubMed ID: 12052855
[TBL] [Abstract][Full Text] [Related]
20. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
Strizzi L; Bianco C; Normanno N; Salomon D
Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
